MAPT and Alzheimer disease: Despite recent genetic evidence demonstrated the existence of a protective APP variant (4, 5) and partially effective anti-amyloid treatments are emerging (6, 7), the amyloid cascade hypothesis is disputed: Braak and Braak, renowned for their staging of AD based on Tau pathology, have presented findings that challenge the centrality of the amyloid cascade hypothesis.